GSK Pharma surges 11%, hits 52-week high on improved outlook

The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.


SI Reporter Mumbai
Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a fresh 52-week high at Rs 1,797, on ralling 11 per cent on the BSE in Thursday’s intra-day trade on improved business outlook. The stock of the drug maker has surpassed its previous high of Rs 1,766 touched on July 27, 2021. It had hit a record high of Rs 1,925 on March 31, 2016.

In the past one month, GSK Pharma has outperformed the market by surging 22 per cent, after the company reported a strong set of numbers for the quarter ended September 2021 (Q2FY22). In comparison, the S&P BSE Sensex was down 4 per cent.

Also Read

RIL Q1 results: Consolidated net profit falls 7% to Rs 12,273 crore

Q1 results: Reliance Jio net profit rises 45% to Rs 3,651 crore

Jio's Q1 net profit rises 45% YoY to Rs 3,651 crore; ARPU at Rs 138

TCS Q1 results: Net profit rises 28.5% to Rs 9,008 cr, misses estimates

PNB posts net profit of Rs 586 crore in Q4; NII rises 48%

Axis Bank, SBI: 5 bank stocks that may give up to 10% return in a month

Govt 'plans tax changes' to help Indian bonds be included in global indexes

RIL gains 3% on plans to hive-off gasification assets into separate unit

IndusInd Bank falls to a 6-month low, down 20% in 3 weeks

Siemens dips 8% on profit booking after Q4 margin disappointment

First Published: Nov 25 2021 | 12:20 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to